PILL holdings
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
Positions
73 stored of 73 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 | Not reported | Not reported | 22.357% | $4.6M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | S&P PHARMACEUTICALS SELECT INDEX SWAP | Not reported | Not reported | 16.356% | $3.4M | Other derivatives | Other | United States | USD |
| 3 | DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | Not reported | Not reported | 8.137% | $1.7M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 4 | S&P PHARMACEUTICALS SELECT INDEX SWAP | Not reported | Not reported | 7.406% | $1.5M | Other derivatives | Other | United States | USD |
| 5 | CRINETICS PHARMACEUTICALS IN | US22663K1079 | 22663K107 | 2.768% | $572K | Equity (common) | Corporate | United States | USD |
| 6 | MBX BIOSCIENCES INC | US55287L1017 | 55287L101 | 2.420% | $500K | Equity (common) | Corporate | United States | USD |
| 7 | S&P PHARMACEUTICALS SELECT INDEX SWAP | Not reported | Not reported | -2.280% | -$471K | Other derivatives | Other | United States | USD |
| 8 | ATAIBECKLEY INC | US04650F1012 | 04650F101 | 2.161% | $446K | Equity (common) | Corporate | United States | USD |
| 9 | Definium Therapeutics, Inc | Not reported | 24477V105 | 2.130% | $440K | Equity (common) | Corporate | Canada | USD |
| 10 | GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT | Not reported | Not reported | 2.034% | $420K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 11 | AMYLYX PHARMACEUTICALS INC | US03237H1014 | 03237H101 | 1.716% | $354K | Equity (common) | Corporate | United States | USD |
| 12 | ENLIVEN THERAPEUTICS INC | US29337E1029 | 29337E102 | 1.685% | $348K | Equity (common) | Corporate | United States | USD |
| 13 | CORCEPT THERAPEUTICS INC Corcept Therapeutics Inc. COM STK USD0.00001 | US2183521028 | 218352102 | 1.667% | $344K | Equity (common) | Corporate | United States | USD |
| 14 | ALUMIS INC | US0223071020 | 022307102 | 1.602% | $331K | Equity (common) | Corporate | United States | USD |
| 15 | NUVATION BIO INC | US67080N1019 | 67080N101 | 1.572% | $325K | Equity (common) | Corporate | United States | USD |
| 16 | TREVI THERAPEUTICS INC | US89532M1018 | 89532M101 | 1.549% | $320K | Equity (common) | Corporate | United States | USD |
| 17 | LIQUIDIA CORP | US53635D2027 | 53635D202 | 1.466% | $303K | Equity (common) | Corporate | United States | USD |
| 18 | NEKTAR THERAPEUTICS | US6402683063 | 640268306 | 1.416% | $292K | Equity (common) | Corporate | United States | USD |
| 19 | AMNEAL PHARMACEUTICALS INC | US03168L1052 | 03168L105 | 1.360% | $281K | Equity (common) | Corporate | United States | USD |
| 20 | BRISTOL-MYERS SQUIBB CO Bristol-Myers Squibb Company COM USD0.10 | US1101221083 | 110122108 | 1.337% | $276K | Equity (common) | Corporate | United States | USD |
| 21 | EDGEWISE THERAPEUTICS INC | US28036F1057 | 28036F105 | 1.328% | $274K | Equity (common) | Corporate | United States | USD |
| 22 | OMEROS CORP | US6821431029 | 682143102 | 1.320% | $273K | Equity (common) | Corporate | United States | USD |
| 23 | LIGAND PHARMACEUTICALS Ligand Pharmaceuticals Incorporated 'B'COM USD0.001 | US53220K5048 | 53220K504 | 1.319% | $272K | Equity (common) | Corporate | United States | USD |
| 24 | ELANCO ANIMAL HEALTH INC Elanco Animal Health Inc COM NPV | US28414H1032 | 28414H103 | 1.311% | $271K | Equity (common) | Corporate | United States | USD |
| 25 | VERADERMICS INC | US9229671048 | 922967104 | 1.284% | $265K | Equity (common) | Corporate | United States | USD |
| 26 | PACIRA PHARMACEUTICALS INC Pacira Biosciences Inc COM USD0.001 | US6951271005 | 695127100 | 1.283% | $265K | Equity (common) | Corporate | United States | USD |
| 27 | VIATRIS INC Viatris Inc COM | US92556V1061 | 92556V106 | 1.267% | $262K | Equity (common) | Corporate | United States | USD |
| 28 | JAZZ PHARMACEUTICALS PLC Jazz Pharmaceuticals PLC COM USD0.0001 | IE00B4Q5ZN47 | G50871105 | 1.253% | $259K | Equity (common) | Corporate | United States | USD |
| 29 | ETON PHARMACEUTICALS INC | US29772L1089 | 29772L108 | 1.247% | $258K | Equity (common) | Corporate | United States | USD |
| 30 | MAZE THERAPEUTICS INC | US5787841007 | 578784100 | 1.245% | $257K | Equity (common) | Corporate | United States | USD |
| 31 | MERCK & COMPANY INC Merck & Co., Inc COM USD0.50 | US58933Y1055 | 58933Y105 | 1.243% | $257K | Equity (common) | Corporate | United States | USD |
| 32 | CSM -N.R CERT HARROW INC | US4158581094 | 415858109 | 1.228% | $254K | Equity (common) | Corporate | United States | USD |
| 33 | JOHNSON & JOHNSON Johnson & Johnson COM USD1.00 | US4781601046 | 478160104 | 1.223% | $253K | Equity (common) | Corporate | United States | USD |
| 34 | ROYALTY PHARMA PLC- CL A Royalty Pharma PLC COM USD0.0001 CLASS A | GB00BMVP7Y09 | G7709Q104 | 1.219% | $252K | Equity (common) | Corporate | United States | USD |
| 35 | INDIVIOR PHARMACEUTICALS INC | US45579U1097 | 45579U109 | 1.195% | $247K | Equity (common) | Corporate | United States | USD |
| 36 | PRESTIGE BRANDS HOLDINGS INC Prestige Consumer Healthcare Inc COM USD0.01 | US74112D1019 | 74112D101 | 1.163% | $240K | Equity (common) | Corporate | United States | USD |
| 37 | COLLEGIUM PHARMACEUTICAL INC Collegium Pharmaceutical Inc. COM USD0.001 | US19459J1043 | 19459J104 | 1.157% | $239K | Equity (common) | Corporate | United States | USD |
| 38 | ORGANON & CO Organon & Co COMMON STOCK | US68622V1061 | 68622V106 | 1.152% | $238K | Equity (common) | Corporate | United States | USD |
| 39 | ELI LILLY & COMPANY Eli Lilly & Co. COM NPV | US5324571083 | 532457108 | 1.146% | $237K | Equity (common) | Corporate | United States | USD |
| 40 | EYEPOINT INC EYEPOINT PHARMACEUTICALS INC | US30233G2093 | 30233G209 | 1.130% | $233K | Equity (common) | Corporate | United States | USD |
| 41 | HARMONY BIOSCIENCES HOLDINGS Harmony Biosciences Holdings Inc COM | US4131971040 | 413197104 | 1.130% | $233K | Equity (common) | Corporate | United States | USD |
| 42 | SUPERNUS PHARMACEUTICALS INC Supernus Pharmaceuticals, Inc COM USD0.001 | US8684591089 | 868459108 | 1.126% | $232K | Equity (common) | Corporate | United States | USD |
| 43 | PFIZER INC Pfizer Inc. COM USD0.05 | US7170811035 | 717081103 | 1.111% | $229K | Equity (common) | Corporate | United States | USD |
| 44 | WAVE LIFE SCIENCES LTD | SG9999014716 | Y95308105 | 1.107% | $229K | Equity (common) | Corporate | United States | USD |
| 45 | PHIBRO ANIMAL HEALTH CORP-A | US71742Q1067 | 71742Q106 | 1.107% | $229K | Equity (common) | Corporate | United States | USD |
| 46 | ANI PHARMACEUTICALS INC ANI Pharmaceuticals Inc. COM USD0.0001 | US00182C1036 | 00182C103 | 1.101% | $227K | Equity (common) | Corporate | United States | USD |
| 47 | TARSUS PHARMACEUTICALS INC | US87650L1035 | 87650L103 | 1.096% | $226K | Equity (common) | Corporate | United States | USD |
| 48 | ZOETIS INC Zoetis Inc. COM USD0.01 CL 'A' | US98978V1035 | 98978V103 | 1.081% | $223K | Equity (common) | Corporate | United States | USD |
| 49 | OCULAR THERAPEUTIX INC | US67576A1007 | 67576A100 | 1.063% | $220K | Equity (common) | Corporate | United States | USD |
| 50 | XERIS BIOPHARMA HOLDINGS INC | US98422E1038 | 98422E103 | 1.059% | $219K | Equity (common) | Corporate | United States | USD |
| 51 | RAPPORT THERAPEUTICS INC | US75383L1026 | 75383L102 | 1.054% | $218K | Equity (common) | Corporate | United States | USD |
| 52 | INNOVIVA INC Innoviva Inc COM USD0.01 | US45781M1018 | 45781M101 | 1.037% | $214K | Equity (common) | Corporate | United States | USD |
| 53 | PERRIGO CO PLC Perrigo Company PLC COM EUR0.001 | IE00BGH1M568 | G97822103 | 1.030% | $213K | Equity (common) | Corporate | United States | USD |
| 54 | AXSOME THERAPEUTICS INC Axsome Therapeutics Incorporation COM USD0.0001 | US05464T1043 | 05464T104 | 1.006% | $208K | Equity (common) | Corporate | United States | USD |
| 55 | AMPHASTAR PHARMACEUTICALS IN Amphastar Pharmaceuticals Inc COM USD0.0001 | US03209R1032 | 03209R103 | 0.922% | $190K | Equity (common) | Corporate | United States | USD |
| 56 | ARVINAS INC Arvinas Inc COM USD0.001 | US04335A1051 | 04335A105 | 0.898% | $185K | Equity (common) | Corporate | United States | USD |
| 57 | ALTO NEUROSCIENCE INC | US02157Q1094 | 02157Q109 | 0.896% | $185K | Equity (common) | Corporate | United States | USD |
| 58 | SEPTERNA INC | US81734D1046 | 81734D104 | 0.760% | $157K | Equity (common) | Corporate | United States | USD |
| 59 | LB PHARMACEUTICALS INC | US50180M1080 | 50180M108 | 0.733% | $151K | Equity (common) | Corporate | United States | USD |
| 60 | CORMEDIX INC | US21900C3088 | 21900C308 | 0.720% | $149K | Equity (common) | Corporate | United States | USD |
| 61 | THERAVANCE BIOPHARMA INC | KYG8807B1068 | G8807B106 | 0.707% | $146K | Equity (common) | Corporate | United States | USD |
| 62 | ACLARIS THERAPEUTICS INC | US00461U1051 | 00461U105 | 0.655% | $135K | Equity (common) | Corporate | United States | USD |
| 63 | PHATHOM PHARMACEUTICALS INC | US71722W1071 | 71722W107 | 0.639% | $132K | Equity (common) | Corporate | United States | USD |
| 64 | ZEVRA THERAPEUTICS INC | US4884452065 | 488445206 | 0.611% | $126K | Equity (common) | Corporate | United States | USD |
| 65 | RELMADA THERAPEUTICS INC | US75955J4022 | 75955J402 | 0.605% | $125K | Equity (common) | Corporate | United States | USD |
| 66 | S&P PHARMACEUTICALS SELECT INDEX SWAP | Not reported | Not reported | 0.602% | $124K | Other derivatives | Other | United States | USD |
| 67 | AQUESTIVE THERAPEUTICS INC | US03843E1047 | 03843E104 | 0.506% | $105K | Equity (common) | Corporate | United States | USD |
| 68 | FULCRUM THERAPEUTICS INC | US3596161097 | 359616109 | 0.503% | $104K | Equity (common) | Corporate | United States | USD |
| 69 | LEXICON GENETICS INCORPORATED LEXICON PHARMACEUTICALS INC | US5288723027 | 528872302 | 0.451% | $93K | Equity (common) | Corporate | United States | USD |
| 70 | BIOAGE LABS INC | US09077V1008 | 09077V100 | 0.412% | $85K | Equity (common) | Corporate | United States | USD |
| 71 | EVOLUS INC | US30052C1071 | 30052C107 | 0.331% | $68K | Equity (common) | Corporate | United States | USD |
| 72 | MALLINCKRODT PLC | IE00BBGT3753 | G5785G107 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 73 | ESPERION THERAPEUTICS INC | US296CVR0207 | 296CVR020 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |